Effects of phospholamban transmembrane mutants on the calcium affinity, maximal activity, and cooperativity of the sarcoplasmic reticulum calcium pump

Biochemistry

Volumn 48, Issue 39, 2009, Pages 9287-9296

  Trieber, Catharine A ^a   Afara, Michael ^a   Young, Howard S ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ATP-ASE ACTIVITY; CALCIUM IONS; CALCIUM TRANSPORT; CONFORMATIONAL CHANGE; COOPERATIVITY; FORWARD RATE CONSTANTS; KINETIC SIMULATION; KINETIC STUDY; PHOSPHOLAMBAN; PROTEOLIPOSOMES; REACTION SCHEMES; SARCOPLASMIC RETICULUM; TRANS-MEMBRANE DOMAINS; TRANSMEMBRANES; VARIABLE EFFECTS; WILD TYPES;

ACTIVATION ANALYSIS; ATMOSPHERIC TEMPERATURE; BIOLOGICAL MEMBRANES; CALCIUM ALLOYS; CELL MEMBRANES; IONS; PLASMA SIMULATION; PUMPS; RATE CONSTANTS;

CALCIUM;

ADENOSINE TRIPHOSPHATASE (CALCIUM); ALANINE; CALCIUM; CALCIUM ION; PHOSPHOLAMBAN; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE;

ARTICLE; CALCIUM BINDING; CHEMICAL REACTION; CONFORMATIONAL TRANSITION; KINETICS; MEMBRANE; MUTANT; NONHUMAN; PRIORITY JOURNAL; PROTEOLIPOSOME; SARCOPLASMIC RETICULUM; WILD TYPE;

ALANINE; ANIMALS; BIOLOGICAL TRANSPORT, ACTIVE; CALCIUM-BINDING PROTEINS; ENZYME ACTIVATION; HUMANS; KINETICS; MEMBRANE PROTEINS; MUTAGENESIS, SITE-DIRECTED; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEOLIPIDS; RABBITS; RECOMBINANT PROTEINS; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES;

EID: 70349632866     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi900852m     Document Type: Article

References (51)

1. Kirchberger, M., Tada, M., and Katz, A. (1975) Phospholamban: A regulatory protein of the cardiac sarcoplasmic reticulum. Recent Adv. Stud. Card. Struct. Metab. 5, 103-115.
2. 2+-ATPase through intramembrane interactions. J. Biol. Chem. 271, 21726-21731.
3. 2+-ATPase of cardiac sarcoplasmic reticulum are critical for functional association with phospholamban. J. Biol. Chem. 273, 14238-14241.
4. 2+-ATPase isoform of cardiac sarcoplasmic reticulum. J. Biol. Chem. 273, 14238-14241.
5. Kimura, Y., Kurzydlowski, K., Tada, M., and MacLennan, D. H. (1997) Phospholamban inhibitory function is enhanced by depolymerization. J. Biol. Chem. 272, 15061-15064.
6. 2+-ATPase forms a functional interaction site with phospholamban. Evidence for physical interactions at other sites. J. Biol. Chem. 274, 32855-32862.
7. 2+ pump and phospholamban in Spodoptera frugiperda (Sf21) cells reveals new insights on ATPase regulation. J. Biol. Chem. 272, 15872-15880.
8. 2+-pump of cardiac sarcoplasmic reticulum. J. Biol. Chem. 275, 41487-41494.
9. Simmerman, H., Kobayashi, Y., Autry, J., and Jones, L. (1996) A leucine zipper stabilizes the pentameric membrane domain of phospholamban and forms a coiled-coil pore structure. J. Biol. Chem. 271, 5941-5946.
10. 2+ pump of cardiac sarcoplasmic reticulum to probe spatial and functional interactions within the transmembrane domain. J. Biol. Chem. 281, 14163-14172.
11. 2+ pump of cardiac sarcoplasmic reticulum. J. Biol. Chem. 280, 10530-10539.
12. 2+ pump revealed with use of heterobifunctional cross-linking agents. J. Biol. Chem. 278, 48348-48356.
13. 2+ ATPase. Proc. Natl. Acad. Sci. U.S.A. 100, 467-472.
14. 2+-ATPase. Biochem. Biophys. Res. Commun. 369, 188-194.
15. 2+-ATPase-Bound Phospholamban in Lipid Bilayers by Solid-State Nuclear Magnetic Resonance (NMR) Spectroscopy. Biochemistry 47, 4369-4376.
16. Inesi, G., Kurzmack, M., and Lewis, D. (1988) Kinetic and equilibrium characterization of an energy-transducing enzyme and its partial reactions. Methods Enzymol. 157, 154-190. (Pubitemid 19020272)
17. Cantilina, T., Sagara, Y., Inesi, G., and Jones, L. R. (1993) Comparative studies of cardiac and skeletal sarcoplasmic reticulum ATPases: Effect of phospholamban antibody on enzyme activation. J. Biol. Chem. 268, 17018-17025.
18. Waggoner, J. R., Huffman, J., Froehlich, J. P., and Mahaney, J. E. (2007) Phospholamban inhibits Ca-ATPase conformational changes involving the E2 intermediate. Biochemistry 46, 1999-2009. (Pubitemid 46272964)
19. Afara, M., Trieber, C., and Young, H. (2008) Peptide inhibitors use two related mechanims to alter the apparent calcium affinity of the sarcoplasmic reticulum calcium pump. Biochemistry 47, 2522-2530.
20. Trieber, C., Douglas, J., Afara, M., and Young, H. (2005) The effects of mutation on the regulatory properties of phospholamban in co-reconstituted membranes. Biochemistry 44, 3289-3297. (Pubitemid 40321999)
21. 2+-ATPase regulatory proteins for high-resolution structural studies. Protein Expression Purif. 40, 118-125.
22. Afara, M., Trieber, C., Glaves, J., and Young, H. (2006) Rational design of peptide inhibitors of the sarcoplasmic reticulum calcium pump. Biochemistry 45, 8617-8627. (Pubitemid 44078882)
23. Warren, G. B., Toon, P. A., Birdsall, N. J. M., Lee, A. G., and Metcalfe, J. C. (1974) Reconstitution of a calcium pump using defined membrane components. Proc. Natl. Acad. Sci. U.S.A. 71, 622-626.
24. Eletr, S., and Inesi, G. (1972) Phospholipid orientation in sarcoplasmic reticulum membranes: Spin-label ESR and proton NMR studies. Biochim. Biophys. Acta 282, 174-179.
25. Stokes, D. L., and Green, N. M. (1990) Three-dimensional crystals of Ca-ATPase from sarcoplasmic reticulum: Symmetry and molecular packing. Biophys. J. 57, 1-14.
26. Reddy, L. G., Jones, L. R., Cala, S. E., O'Brian, J. J., Tatulian, S. A., and Stokes, D. L. (1995) Functional reconstitution of recombinant phospholamban with rabbit skeletal Ca-ATPase. J. Biol. Chem. 270, 9390-9397.
27. 2+-ATPase. Biophys. J. 72, 2545-2558.
28. 2+-ATPase. Ann. N.Y. Acad. Sci. 853, 103-115.
29. 2+-ATPase by cryoelectron microscopy. Biophys. J. 81, 884-894.
30. Kuzmic, P. (1996) Program DYNAFIT for the analysis of enzyme kinetic data: Application to HIV proteinase. Anal. Biochem. 237, 260-273.
31. 2+-ATPase and the pentameric form of phospholamban in two-dimensional co-crystals. Biophys. J. 90, 4213-4223.
32. +2-ATPase: Mechanisms of membrane protein insertion into liposomes during reconstitution procedures involving detergents. Biochim. Biophys. Acta 1107, 283-298.
33. Reddy, L., Cornea, R., Winters, D., McKenna, E., and Thomas, D. (2003) Defining the molecular components of calcium transport regulation in a reconstituted membrane system. Biochemistry 42, 4585-4592. (Pubitemid 36457628)
34. Oxenoid, K., and Chou, J. (2005) The structure of phospholamban pentamer reveals a channel-like architecture in membranes. Proc. Natl. Acad. Sci. U.S.A. 102, 10870-10875.
35. Liu, L. P., and Deber, C. M. (1998) Uncoupling hydrophobicity and helicity in transmembrane segments. α-Helical propensities of the amino acids in non-polar environments. J. Biol. Chem. 273, 23645-23648.
36. 2+-ATPase by phospholamban. Biochem. J. 318, 973-979.
37. 2+ pump ATPase by phospholamban in cardiac sarcoplasmic reticulum. J. Biol. Chem. 267, 1674-1679.
38. 2+ affinity and Vmax (Ca) of calcium transport. J. Biol. Chem. 272, 2852-2860.
39. Antipenko, A., Spielman, A., Sassaroli, M., and Kirchberger, M. (1997) Comparison of the kinetic effects of phospholamban phosphorylation and anti-phospholamban monoclonal antibody on the calcium pump in purified cardiac sarcoplasmic reticulum membranes. Biochemistry 36, 12903-12910. (Pubitemid 27465402)
40. Reddy, L., Autry, J., Jones, L., and Thomas, D. (1999) Co-reconstitution of phospholamban mutants with the Ca-ATPase reveals dependence of inhibitory function on phospholamban structure. J. Biol. Chem. 274, 7649-7655.
41. 2+-ATPases. Proc. Natl. Acad. Sci. U.S.A. 98, 10061-10066.
42. 2+, but not by phospholamban phosphorylation, vanadate, or thapsigargin, and are enhanced by ATP. J. Biol. Chem. 275, 15034-15038.
43. Hutter, M., Krebs, J., Meiler, J., Griesinger, C., Carafoli, E., and Helms, V. (2002) A structural model of the complex formed by phospholamban and the calcium pump of sarcoplasmic reticulum obtained by molecular mechanics. ChemBioChem 3, 1200-1208. (Pubitemid 36005312)
44. Chen, L., Yao, Q., Soares, T., Squier, T., and Bigelow, D. (2009) Phospholamban Modulates the Functional Coupling between Nucleotide Domains in Ca-ATPase Oligomeric Complexes in Cardiac Sarcoplasmic Reticulum. Biochemistry 48, 2411-2421.
45. Ferrington, D., Yao, Q., Squier, T., and Bigelow, D. (2002) Comparable levels of Ca-ATPase inhibition by phospholamban in slow-twitch skeletal and cardiac sarcoplasmic reticulum. Biochemistry 41, 13289-13296. (Pubitemid 35244719)
46. Antipenko, A., Spielman, A. I., and Kirchberger, M. A. (1999) Kinetic differences in the phospholamban-regulated calcium pump when studied in crude and purified cardiac sarcoplasmic reticulum vesicles. J. Membr. Biol. 167, 257-265.
47. Simmerman, H. K., and Jones, L. R. (1998) Phospholamban: Protein structure, mechanism of action, and role in cardiac function. Physiol. Rev. 78, 921-947.
48. 2+/calmodulin-dependent phosphorylation or by interaction with phospholamban. J. Biol. Chem. 271, 14206-14213.
49. Mahaney, J. E., Autry, J. M., and Jones, L. R. (2000) Kinetics studies of the cardiac Ca-ATPase expressed in Sf21 cells: New insights on Ca-ATPase regulation by phospholamban. Biophys. J. 78, 1306-1323.
50. Coll, R. J., and Murphy, A. J. (1984) Purification of the CaATPase of sarcoplasmic reticulum by affinity chromatography. J. Biol. Chem. 259, 14249-14254.
51. Hasenfuss, G., Reinecke, H., Studer, R., Pieske, B., Meyer, M., Drexler, H., and Just, H. (1996) Calcium cycling proteins and force-frequency relationship in heart failure. Basic Res. Cardiol. 91 (Suppl. 2), 17-22.